+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effectiveness of surfactant replacement therapy for preterm infants with respiratory distress syndrome



The effectiveness of surfactant replacement therapy for preterm infants with respiratory distress syndrome



Medical Journal of Malaysia 53(4): 376-384



Thirty preterm infants weighing > or = 800 g with clinical and radiological evidence of respiratory distress syndrome (RDS) requiring mechanical ventilation with FiO2 of > or = 40% were given modified bovine surfactant (Survanta). They were compared with equal number of historical controls. Infants who received surfactant showed prompt and highly significant improvement in FiO2, mean airway pressure, arterial/alveolar oxygen tension ratio and ventilatory index. There was significant improvement in mortality rate (10% vs 33%; p = 0.03). Among the survivors, surfactant-treated infants required shorter duration of continuous positive airway pressure (CPAP) (3.4 vs 9.6 days; p = 0.04). For survivors with birthweight of > 1000 g, surfactant-treated infants required shorter duration of ventilatory support (intermittent positive pressure ventilation + CPAP) (7.5 vs 18.9 days, p = 0.02). Overall, surfactant-treated infants achieved full enteral feeds sooner (15.7 days vs 24.6 days; p = 0.03) and required shorter duration of total parenteral nutrition (13.9 days vs 25.6 days; p = 0.02). We concluded that surfactant replacement therapy was effective in the treatment of preterm infants with RDS.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047628246

Download citation: RISBibTeXText

PMID: 10971981


Related references

Surfactant replacement therapy in preterm neonates with respiratory distress syndrome. Turkey multicentre trial of surfactant replacement therapy. Cocuk Sagligi ve Hastaliklari Dergisi 42(2): 163-171, April-June, 1999

Surfactant replacement in preterm infants with respiratory distress syndrome. Acta Bio-Medica 83(Suppl. 1): 17-20, 2012

Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome. Journal of Perinatal Medicine 37(5): 561-564, 2009

Surfactant therapy in respiratory failure other than respiratory distress syndrome in term and preterm infants. Pediatric Research 31(4 Part 2): 323A, 1992

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond. Turkish Journal of Pediatrics 54(3): 239-246, 2012

Modifications of surfactant phospholipid pattern splp in premature infants with respiratory distress syndrome rds receiving porcine surfactant replacement therapy. Pediatric Research 29(4 Part 2): 319A, 1991

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment. Italian Journal of Pediatrics 40: 40, 2014

Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections. Pediatrics 121(6): 1290-1; Author Reply 1291-2, 2008

Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Pediatrics 86(5): 753-764, 1990

Effect of surfactant replacement therapy on the outcome of premature infants with respiratory distress syndrome. Israel Journal of Medical Sciences 30(4): 267-270, 1994

Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome. Pediatric Pulmonology 24(5): 337-343, 1997

Comparison of outcome of preterm infants with respiratory distress syndrome receiving postnatal steroid therapy with and without surfactant. Pediatric Research 35(4 Part 2): 337A, 1994

Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome. Pediatrics 83(1): 1-6, 1989

A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. Journal of Pediatrics 116(2): 295-300, 1990

Relative changes in oxyhemoglobin, deoxyhemoglobin and intracranial blood volume during surfactant replacement therapy in infants with respiratory distress syndrome. Developmental Pharmacology and Therapeutics 17(3-4): 150-153, 1991